Status:

COMPLETED

Autobone and Bioactive Glass With Ridge Splitting

Lead Sponsor:

Kafrelsheikh University

Conditions:

Horizontal Alveolar Ridge Deficiency

Eligibility:

All Genders

21-50 years

Phase:

NA

Brief Summary

Objective: To compare the use of autogenous bone graft versus autogenous bone graft mixed with bioactive glass bone graft in the treatment of maxillary anterior horizontal bone defects by ridge splitt...

Detailed Description

Participants' selection: 22 patients, aged from 18 to 50 years, were selected in this prospective, randomized and blinded clinical trial from the Outpatient Clinic of the Department of Oral Medicine ...

Eligibility Criteria

Inclusion

  • good general health at the time of surgery
  • at least 3months postextraction healing period
  • horizontally compromised maxillary anterior alveolar ridges (at least 3mm bone width and 13mm bone vertical height).

Exclusion

  • vertical bone defect
  • thick labial cortex with less cancellous bone inside
  • obvious undercut on the labial/buccal side
  • uncontrolled periodontal conditions
  • history of radiotherapy in the head and neck region
  • uncontrolled diabetes mellitus or other systematic disorders
  • smokers
  • pregnancy
  • non-compliant patients
  • allergic reaction to the used medications.

Key Trial Info

Start Date :

April 17 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 15 2021

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT04814160

Start Date

April 17 2020

End Date

April 15 2021

Last Update

May 4 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

faculty of dentistry, kafrelsheikh University

Kafr ash Shaykh, Egypt, 214312